In one paragraphArticle in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
11 authors.
Mariarosaria De RosaUPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213-1863, USA.
Theresa M HeidenreichUPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213-1863, USA.ORCID 0009-0008-3449-6071 Libby ChildsUPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213-1863, USA.
Benura AzerogluLaboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0001-7243-384X Sneh M TopraniDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.ORCID 0000-0002-2388-5425 Nader AryamaneshBioinformatics Unit, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW 2145, Australia.ORCID 0000-0003-4666-9175 Pablo GalavizBioinformatics Unit, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW 2145, Australia.ORCID 0000-0001-7170-3166 Hilda A PickettTelomere Length Regulation Unit, Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW 2145, Australia.
Eros Lazzerini DenchiLaboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Zachary D NagelDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Patricia L OpreskoUPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213-1863, USA.ORCID 0000-0002-6470-2189 Funding
Supplement to Promote DiversityR35ES030396 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Patricia L Opresko · 2019 to 2026
$7.5MDetermine the mechanism of ALT-mediated telomere elongationZIABC011816 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LAZZERINI DENCHI, EROS · 2018 to 2025
$4.8MRoles of Telomeric Oxidative DNA Lesions in Telomere Length RegulationR01CA207342 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sua Myong, Patricia L Opresko · 2017 to 2026
$3.7MMulti-Pathway DNA Repair Capacity Measurements in Lung Cancer Patients and Healthy ControlsU01ES029520 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI CHRISTIANI, DAVID C, ENGELWARD, BEVIN P. · 2018 to 2022
$3.3MDevelopmental regulation of apoptosis as a modifiable driver of radiotherapy-induced neurocognitive impairment in pediatric patientsR37CA248565 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Kristopher Andrew Sarosiek · 2020 to 2026
$2.6MInvestigating roles for oxidative guanine damage in transcription regulationK99ES035871 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DE ROSA, MARIAROSARIA · 2024 to 2025
$221kIntramural NIH HHS ZIA BC011816National Health and Medical Research Council 2043344National Institutes of Health (NIH), Intramural Research Program (USA) 1ZIABC011816NCI NIH HHS R01 CA207342NCI NIH HHS R01CA207342NCI NIH HHS R37 CA248565NCI NIH HHS R37CA248565NIEHS NIH HHS K99 ES035871NIEHS NIH HHS K99ES035871NIEHS NIH HHS R35 ES030396NIEHS NIH HHS R35ES030396NIEHS NIH HHS U01 ES029520NIH HHS U01ES029520
6 · The paper itselfAbstract
Telomeres are highly susceptible to oxidative DNA damage, particularly 8-oxoguanine (8-oxoG), which is processed by glycosylase-initiated base excision repair (BER). OGG1 removes 8-oxoG opposite C, and MUTYH removes A misinserted opposite 8-oxoG to prevent mutations. While OGG1 has an established role in telomere protection, the contribution of MUTYH to telomere stability in cancer cells after oxidative DNA damage remains poorly understood. Using a chemoptogenetic system to induce targeted 8-oxoG lesions specifically at telomeres in HeLa cancer cells, we demonstrate that MUTYH is required to prevent telomere shortening, telomere loss, and genomic instability after chronic damage. Yet, telomere damage in MUTYH-deficient cells does not cause sustained DNA damage signaling or reduced cellular proliferation. Whole-genome sequencing further reveals enrichment of G to T transversions within telomeric repeats in MUTYH-deficient cells, consistent with increased mutagenesis due to unrepaired 8-oxoG:A mispairs. Combined loss of MUTYH and OGG1 rescues damage-induced telomere aberrations and genomic instability, implicating BER-generated single-strand break (SSB) intermediates as major contributors to telomere instability. In agreement, exo-FISH and S1-END-seq analyses reveal that repair-proficient cells rapidly accumulate SSB intermediates after damage, which are later resolved, whereas glycosylase-deficient cells exhibit SSBs at later time points. Together, these findings identify MUTYH as a critical guardian of telomere integrity during chronic oxidative stress and provide insight into how defective BER at telomeres contributes to genomic instability in cancer cells, with implications for cancers associated with MUTYH deficiency and mutations.
Indexed as
DNA DamageDNA GlycosylasesGuanineNeoplasmsTelomereDNA RepairExcision RepairGenomic InstabilityHeLa CellsHumansOxidative Stress8-hydroxyguanineDNA GlycosylasesGuaninemutY adenine glycosylaseoxoguanine glycosylase 1, human8-oxoguaninebase excision repaircancer cellsgenomic instabilityMUTYHoxidative DNA damagesingle-strand breakstelomeres
Identifiers
PMID42793066
PMCPMC13604166
What OpenQuestion holds
Textmetadata
Read underepoch 390